281 related articles for article (PubMed ID: 17112452)
1. Testicular cancer. Clinical practice guidelines in oncology.
Motzer RJ; Bolger GB; Boston B; Carducci MA; Fishman M; Hancock SL; Hauke RJ; Hudes GR; Jonasch E; Kantoff P; Kuzel TM; Lange PH; Levine EG; Logothetis C; Margolin KA; Pohar KS; Redman BG; Robertson CN; Samlowski WE; Sheinfeld J;
J Natl Compr Canc Netw; 2006 Nov; 4(10):1038-58. PubMed ID: 17112452
[No Abstract] [Full Text] [Related]
2. Prognostic factors in nonseminomatous testicular cancer.
Javadpour N
Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
[No Abstract] [Full Text] [Related]
3. Prognostic factors in metastatic disease.
Droz JP; Kramar A; Rey A
Semin Oncol; 1992 Apr; 19(2):181-9. PubMed ID: 1372760
[No Abstract] [Full Text] [Related]
4. Treatment options for stage I nonseminoma.
Feldman DR
J Clin Oncol; 2014 Dec; 32(34):3797-800. PubMed ID: 25366681
[No Abstract] [Full Text] [Related]
5. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
[TBL] [Abstract][Full Text] [Related]
6. NCCN clinical practice guidelines in oncology: testicular cancer.
Motzer RJ; Agarwal N; Beard C; Bolger GB; Boston B; Carducci MA; Choueiri TK; Figlin RA; Fishman M; Hancock SL; Hudes GR; Jonasch E; Kessinger A; Kuzel TM; Lange PH; Levine EG; Margolin KA; Michaelson MD; Olencki T; Pili R; Redman BG; Robertson CN; Schwartz LH; Sheinfeld J; Wang J
J Natl Compr Canc Netw; 2009 Jun; 7(6):672-93. PubMed ID: 19555582
[No Abstract] [Full Text] [Related]
7. Testicular cancer: risk stratification in adolescents with nonseminoma.
Looijenga LH
Nat Rev Urol; 2014 Jul; 11(7):367-8. PubMed ID: 24960597
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of A.F.P. and H.C.G. in testicular tumours of germ-cell origin.
Lancet; 1978 Nov; 2(8098):1042. PubMed ID: 82048
[No Abstract] [Full Text] [Related]
9. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
Schwartz MK
Tumour Biol; 1987; 8(2-3):106-8. PubMed ID: 2452467
[No Abstract] [Full Text] [Related]
10. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.
von Eyben FE; Blaabjerg O; Madsen EL; Petersen PH; Smith-Sivertsen C; Gullberg B
Eur J Cancer; 1992; 28(2-3):410-5. PubMed ID: 1375486
[TBL] [Abstract][Full Text] [Related]
11. The present and future of serum diagnostic tests for testicular germ cell tumours.
Murray MJ; Huddart RA; Coleman N
Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472
[TBL] [Abstract][Full Text] [Related]
12. Management of clinical stage I nonseminomatous germ cell testicular cancer.
Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
[TBL] [Abstract][Full Text] [Related]
13. Germ cell tumours of testis: prognostic factors and results.
Nikzas D; Champion AE; Fox M
Eur Urol; 1990; 18(4):242-7. PubMed ID: 1705226
[TBL] [Abstract][Full Text] [Related]
14. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U
Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of seminoma patients with serum markers.
Hotakainen K; Lempiäinen A; Stenman UH
Cancer; 2013 Jul; 119(13):2511. PubMed ID: 23584987
[No Abstract] [Full Text] [Related]
17. Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors.
Arrieta O; Michel Ortega RM; Angeles-Sánchez J; Villarreal-Garza C; Avilés-Salas A; Chanona-Vilchis JG; Aréchaga-Ocampo E; Luévano-González A; Jiménez MA; Aguilar JL
J Exp Clin Cancer Res; 2009 Aug; 28(1):120. PubMed ID: 19709439
[TBL] [Abstract][Full Text] [Related]
18. Reply to Monitoring of seminoma patients with serum markers.
Vesprini D; Warde P; Chung P
Cancer; 2013 Jul; 119(13):2511-2. PubMed ID: 23584974
[No Abstract] [Full Text] [Related]
19. Testicular cancer: role of biological tumor markers.
Pearson JC; Spaulding JT; Friedman MA
Cancer Treat Rev; 1979 Dec; 6(4):217-21. PubMed ID: 93978
[No Abstract] [Full Text] [Related]
20. Diagnostic value of markers AFP, HCG and LDH in advanced germ cell tumors before and after cytostasis resp.
Jaeger N; Vahlensieck W
Prog Clin Biol Res; 1985; 203():107-16. PubMed ID: 2421323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
